Merck

Germany’s Merck Extends AZ Offer a Fifth Time

Codexis Reports Fourth Quarter and Full Year 2013 Results

Zachert to Take up Post as Lanxess CEO on April 1

Lanxess Expects Net Loss for Full Year 2013

Bayer, Novartis said to Eye Merck & Co consumer health unit

Merck Extends Offer for AZ Electronics Until Mid-March

Reckitt Benckiser Says Pharma Review Ongoing

Merck & Co to Pay $100 Million in Contraceptive Suit

Merck KGaA Again Extends Deadline for AZ Electronics Takeover

Merck KGaA Extends Takeover Deadline for AZ Electronics

Zachert to Replace Heitmann as Lanxess CEO in May

Merck KGaA Sells Bioanalytics Business

German Chemical Producers Weigh in on Export Surplus Complaints

Merck posts offer to acquire AZ Electronic Materials

Merck Serono in Spanish Drug Development Pact

Consumer Health Division of Merck KGaA in Turnaround

Merck KGaA Offers $2.6 Billion for AZ Electronic Materials

Merck KGaA to Build New Pharma Plant in China

Germany’s Merck Adds Israeli R&D Partners

Merck Serono and Selvita in Oncology R&D Pact

Roche to Spend $880 Million on Manufacturing, Create 500 Jobs

Germany's Merck Sees Long-Term Growth in Cancer Drug Erbitux

Merck KGaA to Continue Testing Cancer Vaccine

India Revokes GSK Cancer Drug Patent In Latest Big Pharma Blow

Pfizer, Merck Weather Weak Quarter

Bexsero Setback hits Novartis’ Vaccine Division

GSK Says Executives Appear To Have Broken Chinese law

China Widens Drug Industry Probe, Visits Belgium’s UCB

China Blocks GSK Finance Head From Leaving Country

China Launches Pharma Crackdown

China Says GSK Execs Confess To Bribery and Tax Crimes

GlaxoSmithKline Examines Chinese Botox Sales Tactics

Merck KGaA Gets Credit Ratings Upgrade from Moody's, S&P

Pfizer, Novartis May Join Amgen in Bidding for Onyx

European Medicines Agency Pave Way for Biosimilar Drug Breakthrough

81 more articles

Top-Feature

Evonik Industries AG

Safer, Scalable Pharmaceutical Manufacturing with Flow Chemistry

CHEManager International c/o Wiley-VCH GmbH

Upcoming Virtual Events

Agilent Technologies Inc.

Comprehensive Insights into Antibody–Drug Conjugates (ADC) for Precision Cancer Therapy

Global Impact Coalition (GIC)

Siemens Joins the Global Impact Coalition

Expert Insights

ADCs for Precision Cancer Therapy

Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.